Lung cancer remains a leading cause of cancer-related deaths worldwide, with cigarette smoking being a primary risk factor. Nicotine, a key component of cigarette smoke, promotes lung cancer progression through specific molecular pathways.
This review discusses the potential role of licorice chalcones in modulating these pathways, offering insights into new therapeutic strategies for nicotine-induced non-small cell lung cancer.